Palatin Technologies, Inc. (PTN)
NASDAQ: PTN · Real-Time Price · USD
7.77
-0.10 (-1.27%)
At close: Aug 7, 2026, 4:00 PM EDT
7.75
-0.02 (-0.30%)
After-hours: Aug 7, 2026, 5:55 PM EDT
Palatin Technologies Market Cap
Palatin Technologies has a market cap or net worth of $14.02 million as of August 7, 2026. Its market cap has increased by 22.99% in one year.
Market Cap
14.02M
Enterprise Value
4.15M
1-Year Change
22.99%
Ranking
Category
Stock Price
$7.77
ChartMarket Cap Chart
Since December 1, 1998, Palatin Technologies's market cap has decreased from $18.60M to $14.02M, a decrease of -24.62%. That is a compound annual growth rate of -1.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 14.02M | -46.49% |
| Dec 31, 2025 | 26.20M | 20.74% |
| Dec 31, 2024 | 21.70M | -60.33% |
| Dec 29, 2023 | 54.70M | 106.42% |
| Dec 30, 2022 | 26.50M | -77.62% |
| Dec 31, 2021 | 118.40M | -23.81% |
| Dec 31, 2020 | 155.40M | -13.28% |
| Dec 31, 2019 | 179.20M | 24.53% |
| Dec 31, 2018 | 143.90M | -11.99% |
| Dec 29, 2017 | 163.50M | 199.45% |
| Dec 30, 2016 | 54.60M | 20.80% |
| Dec 31, 2015 | 45.20M | 56.94% |
| Dec 31, 2014 | 28.80M | - |
| Dec 31, 2013 | 28.80M | 23.08% |
| Dec 31, 2012 | 23.40M | 67.14% |
| Dec 30, 2011 | 14.00M | -12.50% |
| Dec 31, 2010 | 16.00M | -54.93% |
| Dec 31, 2009 | 35.50M | 355.13% |
| Dec 31, 2008 | 7.80M | -54.12% |
| Dec 31, 2007 | 17.00M | -88.28% |
| Dec 29, 2006 | 145.10M | -24.27% |
| Dec 30, 2005 | 191.60M | 33.43% |
| Dec 31, 2004 | 143.60M | 28.56% |
| Dec 31, 2003 | 111.70M | 197.87% |
| Dec 31, 2002 | 37.50M | -20.21% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NewcelX | 18.04M |
| Lipocine | 17.73M |
| Tvardi Therapeutics | 17.17M |
| Citius Pharmaceuticals | 16.72M |
| Cyclerion Therapeutics | 15.61M |
| Moolec Science | 15.58M |
| OSR Health | 15.31M |
| Pasithea Therapeutics | 15.16M |